BerandaREGN • NASDAQ
add
Regeneron Pharmaceuticals Inc
$783,71
Setelah Jam Perdagangan Normal:(0,41%)-3,21
$780,50
Tutup: 24 Des, 14.26.44 GMT-5 · USD · NASDAQ · Pernyataan Penyangkalan
Tutup sebelumnya
$785,17
Rentang hari
$783,61 - $792,77
Rentang tahun
$476,49 - $792,77
Kapitalisasi pasar
82,37Â M USD
Volume Rata-Rata
1,12Â jt
Rasio P/E
18,76
Hasil dividen
0,45%
Bursa utama
NASDAQ
Dalam berita
Keuangan
Laporan Laba Rugi
Pendapatan
Penghasilan bersih
| (USD) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 3,75Â M | 0,90% |
Biaya operasional | 647,80Â jt | -9,32% |
Penghasilan bersih | 1,46Â M | 8,91% |
Margin laba bersih | 38,89 | 7,94% |
Penghasilan per saham | 11,83 | -5,06% |
EBITDA | 1,25Â M | -8,70% |
Tarif pajak efektif | 17,20% | — |
Neraca
Total aset
Total liabilitas
| (USD) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 8,44Â M | -13,81% |
Total aset | 40,17Â M | 7,28% |
Total liabilitas | 9,21Â M | 13,50% |
Total ekuitas | 30,96 M | — |
Saham yang beredar | 102,60 jt | — |
Harga terhadap nilai buku | 2,61 | — |
Tingkat pengembalian aset | 7,08% | — |
Tingkat pengembalian modal | 8,37% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Penghasilan bersih | 1,46Â M | 8,91% |
Kas dari operasi | 1,62Â M | 25,36% |
Kas dari investasi | -402,90Â jt | 29,86% |
Kas dari pembiayaan | -717,90Â jt | -13,23% |
Perubahan kas bersih | 497,50Â jt | 495,10% |
Arus kas bebas | 1,42Â M | 86,68% |
Tentang
Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988. Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its present name; the company has since expanded operations into the study of both cytokine and tyrosine kinase receptors, which gave rise to their first product, which is a VEGF-trap. Wikipedia
Didirikan
1988
Kantor pusat
Situs
Karyawan
15.222
